Armistice Capital’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.4M Sell
6,012,000
-312,000
-5% -$665K 0.57% 65
2025
Q4
$10.2M Buy
6,324,000
+364,000
+6% +$572K 0.25% 101
2025
Q3
$10M Hold
5,960,000
0.31% 85
2025
Q2
$7.21M Sell
5,960,000
-336,000
-5% -$487K 0.27% 83
2025
Q1
$8M Buy
6,296,000
+20,000
+0.3% +$52.2K 0.21% 97
2024
Q4
$20.4M Buy
6,276,000
+18,000
+0.3% +$64.8K 0.47% 71
2024
Q3
$20.6M Buy
6,258,000
+258,000
+4% +$1.01M 0.54% 63
2024
Q2
$25.5M Buy
6,000,000
+3,600,000
+150% +$35.1M 0.67% 55
2024
Q1
$35.3M Sell
2,400,000
-2,172,000
-48% -$32.8M 0.94% 36
2023
Q4
$44M Sell
4,572,000
-140,000
-3% -$968K 1.17% 30
2023
Q3
$22M Sell
4,712,000
-888,000
-16% -$4.42M 0.65% 53
2023
Q2
$30M Sell
5,600,000
-360,000
-6% -$2.22M 0.75% 48
2023
Q1
$42.7M Sell
5,960,000
-132,000
-2% -$795K 0.99% 38
2022
Q4
$40.9M Sell
6,092,000
-36,000
-0.6% -$197K 1.1% 34
2022
Q3
$21.2M Hold
6,128,000
0.53% 57
2022
Q2
$18.1K Buy
6,128,000
+1,128,000
+23% +$5.93M 0.32% 65
2022
Q1
$44M Buy
5,000,000
+2,300,000
+85% +$25.4M 1.25% 36
2021
Q4
$43.3M Buy
+2,700,000
New +$50.8M 1.05% 38

Other funds holding MGNX